Abstract

Assess the importance of overall time (OT) and dose for biochemical failure (BF) after external-beam radiotherapy of prostate cancer in a retrospective analysis of a nine-institution database with 4839 patients treated at the institutions of our collaborators EM Horwitz (Fox Chase Cancer Center), P Kupelian (UCLA), A Martinez (William Beaumont Hospital), J Michalski (Mallinckrodt Institute of Radiology), T Pisansky (Mayo Medical School), H Sandler (University of Michigan), WU Shipley and A Zietman (Massachusetts General Hospital), and M Zelefsky (Memorial Sloan Kettering Cancer Center).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call